Gymnotic uptake of AntimiRs alter microRNA-34a levels in 2D and 3D epithelial cell culture
MicroRNAs are attractive therapeutic targets in many diseases, including chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Among microRNA inhibitors antimiRs have been proven successful in lowering aberrant microRNA levels in the clinic. We present a set of antimiRs targeting...
Main Authors: | Julie Weidner, Ewa Kolosionek, Reetta Holmila, Elisabeth Ax, Marion Garreau, Felix Gnerlich, Henric Olsson, Werngard Czechtizky, Stefan Vollmer, Anna M. Rydzik |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S216225312300224X |
Similar Items
-
Investigation of PLGA nanoparticles in conjunction with nuclear localization sequence for enhanced delivery of antimiR phosphorothioates in cancer cells in vitro
by: Shipra Malik, et al.
Published: (2019-04-01) -
Development of microRNA therapeutics is coming of age
by: Eva van Rooij, et al.
Published: (2014-06-01) -
Targeted Expression to Liver of an antimiR-33 Sponge as a Gene Therapy Strategy against Hypercholesterolemia: In Vitro Study
by: Mariela Montaño-Samaniego, et al.
Published: (2023-08-01) -
Formulation of PLGA nanoparticles containing short cationic peptide nucleic acids
by: Shipra Malik, et al.
Published: (2020-01-01) -
AntimiR targeting of microRNA-134 reduces seizures in a mouse model of Angelman syndrome
by: Aoife Campbell, et al.
Published: (2022-06-01)